Account
Hero background pattern

From launching your product to training your team

Remap Consulting is the pricing and market access launch partner to help you launch with confidence.

Launch implementation

Develop and implement a pricing and market access launch strategy for your product

Learn more

Price Optimization

Having the right pharma pricing strategy is essential for your product to optimize revenues.

Learn more

Price & Market Access Training

We aim to make the transfer of knowledge more flexible, effective, and engaging.

Learn more

We work with people who’re asking:

Optimal price
What is the optimal price for our product?
Right evidence
Do we have the right evidence to support price and access to launch?
Training people
Do we have the right capabilities to train people on market access?
Market access potential
What is the pricing and market access potential for BD opportunities?

Discover the latest insights

Fimea launches pilot procedure for the evaluation …
Fimea program aims to standardise the initiation of assessment which are currently different for out…
Read more
windsor framework
The Project Orbis initiative
The Project Orbis initiative is an international partnership between medicines regulators in the UK,…
Read more
generics
Italy AIFA reports on manufacturer paybacks
Collectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep…
Read more
market access
PMA Insights: Week 7
We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi…
Read more
Spain’s Ministry of Health copies NICE, and …
Spain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late…
Read more
combination pricing
Germany – European joint assessment at deadlock …
Germany’s BPI and vfa advise that the implementation of the European Health Technology Assessment (E…
Read more
What are the 5 Pricing & Market Access trends …
Our experts provide an overview of the five key trends that could shape the pricing and market acces…
Read more
market access
PMA Insights: Week 1
We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi…
Read more
EU HTA – looking back on 2022
Our market access experts cover the changes to the joint EU HTA process that occurred in 2022 and wh…
Read more
Are you ready for the new EU HTA in 2025?
Webinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint …
Read more